Rhenman & Partners Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Rhenman & Partners Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-60,000	Closed	-$3.57M	–	98
2021 Q3	$3.57M	Hold	60,000	–	–	0.25%	82
2021 Q2	$4.09M	Hold	60,000	–	–	0.28%	84
2021 Q1	$4.16M	Sell	60,000 -10,000	-14%	-$769K	0.29%	79
2020 Q4	$5.38M	Sell	70,000 -140,778	-67%	-$10.6M	0.44%	67
2020 Q3	$15.8M	Hold	210,778	–	–	1.4%	32
2020 Q2	$13.3M	Sell	210,778 -29,222	-12%	-$1.61M	1.43%	29
2020 Q1	$10.1M	Buy	240,000 +20,000	+9%	+$917K	1.41%	29
2019 Q4	$9.99M	Buy	220,000 +65,000	+42%	+$3.07M	1.1%	40
2019 Q3	$7.09M	Sell	155,000 -15,000	-9%	-$843K	0.89%	45
2019 Q2	$9.97M	Sell	170,000 -64,558	-28%	-$3.34M	1.1%	38
2019 Q1	$10.5M	Sell	234,558 -137,300	-37%	-$6.3M	1.23%	33
2018 Q4	$14.5M	Buy	371,858 +5,471	+1%	+$215K	1.66%	24
2018 Q3	$16.9M	Buy	366,387 +81,766	+29%	+$3.31M	1.69%	25
2018 Q2	$12.4M	Sell	284,621 -1,021	-0.4%	-$43.9K	1.27%	37
2018 Q1	$11.3M	Sell	285,642 -100,000	-26%	-$3.89M	1.39%	33
2017 Q4	$13.1M	Sell	385,642 -183,849	-32%	-$5.24M	1.77%	22
2017 Q3	$14.5M	Buy	+569,491	New	+$13.1M	1.85%	18

Other funds holding ARNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rhenman & Partners Asset Management's ARNA Position: Q4 2021 in Review

Rhenman & Partners Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 60,000 shares — an estimated $3.57M sold.

Rhenman & Partners Asset Management first reported a position in ARNA in Q3 2017 and held it in 17 quarters. The position peaked at $16.9M in Q3 2018. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

Rhenman & Partners Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
Rhenman & Partners Asset Management sold 60,000 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $3.57M.
Rhenman & Partners Asset Management first reported a position in Arena Pharmaceuticals Inc in Q3 2017 and held it in 17 quarters.
Rhenman & Partners Asset Management's Arena Pharmaceuticals Inc position peaked at $16.9M in Q3 2018.
316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.